AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

The most recent trading session ended with Astrazeneca (AZN ... to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual ...

AstraZeneca and Gilead are both staying tight ... gauge its responsiveness to what would be the biggest merger in pharma history, and the report has inevitably sparked a lot of debate about ...

AstraZeneca has a single ... and treatments are progressing faster in oncology now than at any other time in history. Given the pace of innovation, and the need to improve on current and potential ...

If you suffered substantial losses and wish to serve as lead plaintiff of the AstraZeneca class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn ...

Drugmakers AstraZeneca (AZN) and Daiichi Sankyo’s (DSKYF) cancer drug, Enhertu, has been added to China’s National Reimbursement Drug List (NRDL) and will be covered by state-run medical ...

Delivering humanitarian aid to people affected by conflict and violence in Nigeria. AstraZeneca, the global pharmaceutical company, supports the British Red Cross to help those affected by conflict ...